Nektar Therapeutics
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2011 | $71.5M | $-123.9M | $-134.0M |
| FY2012 | $81.2M | $-141.2M | $-171.9M |
| FY2013 | $148.9M | $-120.1M | $-162.0M |
| FY2014 | $200.7M | $-16.5M | $-53.9M |
| FY2015 | $230.8M | $-29.4M | $-81.2M |
| FY2016 | $165.4M | $-112.9M | $-153.5M |
| FY2017 | $307.7M | $-59.6M | $-96.7M |
| FY2018 | $1.19B | $687.9M | $681.3M |
| FY2019 | $114.6M | $-440.0M | $-440.7M |
| FY2020 | $152.9M | $-425.1M | $-444.4M |
| FY2021 | $101.9M | $-446.1M | $-523.8M |
| FY2022 | $92.1M | $-376.2M | $-368.2M |
| FY2023 | $90.1M | $-263.7M | $-276.1M |
| FY2024 | $98.4M | $-105.2M | $-119.0M |
| FY2025 | $55.2M | $-140.1M | $-164.1M |